RC
KZR

RBF Capital’s Kezar Life Sciences KZR Stock Holding History

RBF Capital’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,144
Closed -$209K – 521
2026
Q1 		$209K Hold
28,144
– – 0.01% 457
2025
Q4 		$177K Sell
28,144
-109
-0.4% -$636 0.01% 525
2025
Q3 		$110K Hold
28,253
– – ﹤0.01% 551
2025
Q2 		$129K Hold
28,253
– – 0.01% 556
2025
Q1 		$138K Hold
28,253
– – 0.01% 534
2024
Q4 		$190K Buy
28,253
+1
+0% +$7 0.01% 504
2024
Q3 		$218K Hold
28,252
– – 0.01% 539
2024
Q2 		$170K Buy
+28,252
New +$215K 0.01% 529
2021
Q2 		– Sell
-1,215
Closed -$72K – 494
2021
Q1 		$72K Sell
1,215
-4,100
-77% -$240K ﹤0.01% 441
2020
Q4 		$277K Hold
5,315
– – 0.02% 322
2020
Q3 		$257K Hold
5,315
– – 0.03% 294
2020
Q2 		$275K Hold
5,315
– – 0.03% 304
2020
Q1 		$232K Sell
5,315
-3,630
-41% -$148K 0.03% 300
2019
Q4 		$359K Buy
+8,945
New +$275K 0.03% 285

RBF Capital's KZR Position: Q2 2026 in Review

RBF Capital sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 28,144 shares — an estimated $209K sold.

RBF Capital first reported a position in KZR in Q4 2019 and held it in 14 quarters. The position peaked at $359K in Q4 2019. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

  • RBF Capital reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
  • RBF Capital sold 28,144 Kezar Life Sciences shares in Q2 2026, an estimated $209K.
  • RBF Capital first reported a position in Kezar Life Sciences in Q4 2019 and held it in 14 quarters.
  • RBF Capital's Kezar Life Sciences position peaked at $359K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on RBF Capital's 13F filing for Q2 2026, filed 14 Aug 2026.